While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2021.
from RTT - Earnings https://ift.tt/2Wwban9
via IFTTT
No comments:
Post a Comment